<DOC>
	<DOCNO>NCT02674672</DOCNO>
	<brief_summary>To establish clinical safety efficacy VenaTech® Retrievable Vena Cava Filter</brief_summary>
	<brief_title>A Safety Efficacy Study Implantation Retrieval Procedures Using VENATECH® Retrieval Filter System</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>Pulmonary thromboembolism contraindication anticoagulation . Failure anticoagulant therapy thromboembolic disease . Prevention pulmonary embolism patient recent history ( &lt; 3 month ) DVT/ PE need undergo urgent surgery high risk DVT/PE temporary contraindication use therapeutic dos anticoagulant . Emergency treatment follow massive pulmonary embolism anticipate benefit conventional therapy reduce Chronic , recurrent pulmonary embolism anticoagulant therapy fail contraindicate The filter implant patient : A vena cava diameter &lt; 14 mm &gt; 28 mm ( due risk device migration ) Risk septic embolism Known allergy material contain kit , allergy contrast medium . Severely disabled patient whose lifeexpectancy , 6 month , appear limited accord investigator 's opinion . In addition , exclusion criterion also extend : Patients regularly follow participate center Subject already implant vena cava filter Subject duplicate IVC Subject contrast allergy iodinate contrast noniodinated contrast material Subject unable understand information participation study due language barrier , intellectual deficiency , psychiatric problems… Subject renal failure ( creatinemia clearance &lt; 30ml/min )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>VenaTech® Retrievable Vena Cava Filter</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
</DOC>